Cargando…

244P Alternate-day hypofractionated radiotherapy for radical treatment of head & neck cancer during the COVID-19 pandemic: A single institute experience

Detalles Bibliográficos
Autores principales:	Singh, P., Joseph, D.M., Krishnan, A.S., Ahuja, R., Gupta, S., Gupta, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719674/ http://dx.doi.org/10.1016/j.annonc.2022.10.279

Ejemplares similares

Hypofractionated Radiotherapy for Palliation in Locally Advanced Head and Neck Cancer
por: Spartacus, RK, et al.
Publicado: (2017)

An Extended Hypofractionated Palliative Radiotherapy Regimen for Head and Neck Carcinomas
por: Laursen, Michael, et al.
Publicado: (2018)

Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era
por: Gupta, Tejpal, et al.
Publicado: (2020)

Radical radiotherapy with concurrent weekly cisplatin in loco-regionally advanced squamous cell carcinoma of the head and neck: a single-institution experience
por: Gupta, Tejpal, et al.
Publicado: (2009)

Hypofractionated Palliative Radiotherapy in Locally Advanced Inoperable Head and Neck Cancer: CMC Vellore Experience
por: Das, Saikat, et al.
Publicado: (2013)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

Hypofractionated Radiotherapy in Head and Neck Cancer Elderly Patients: A Feasibility and Safety Systematic Review for the Clinician
por: Piras, Antonio, et al.
Publicado: (2021)

CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
por: Agresta, Laura, et al.
Publicado: (2020)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
por: Vreugdenhil, M., et al.
Publicado: (2021)

Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
por: Zhao, Ruizhi, et al.
Publicado: (2020)

Hypofractionated radiotherapy in breast cancer: a 10-year single institution experience
por: Najas, Gabriel Faria, et al.
Publicado: (2021)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
por: Dubinsky, Pavol, et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy
por: Yamazaki, Hideya, et al.
Publicado: (2011)

Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group
por: Nguyen, Nam P., et al.
Publicado: (2023)

Effectiveness of radiotherapy for head and neck skin cancers: a single-institution study
por: Kim, Jae Wang, et al.
Publicado: (2019)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
por: Lee, Dong Soo, et al.
Publicado: (2012)

Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 “QUAD shot” regimen for incurable head and neck cancer
por: Toya, Ryo, et al.
Publicado: (2020)

A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients
por: Rastogi, Kartick, et al.
Publicado: (2018)

Hypofractionated radiotherapy for early glottic cancer: a retrospective interim analysis of a single institution
por: Lee, Jeong Won, et al.
Publicado: (2019)

Three-week hypofractionated radiotherapy in early glottic cancer—a single institution retrospective study
por: Sudha, Arun Sankar, et al.
Publicado: (2022)

Predicting radiotherapy-induced xerostomia in head and neck cancer patients using day-to-day kinetics of radiomics features
por: Berger, Thomas, et al.
Publicado: (2022)

PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
por: Dhouib, F., et al.
Publicado: (2022)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Hypofractionated External-Beam Radiotherapy for Prostate Cancer
por: Cho, L. Chinsoo, et al.
Publicado: (2013)

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy
por: Inoue, Hiroshi K, et al.
Publicado: (2015)

Hypofractionated whole breast radiotherapy: current perspectives
por: Koulis, Theodora A, et al.
Publicado: (2015)

Hypofractionated radiotherapy to treat acne keloidalis nuchae
por: Kwan, Jennifer Yin Yee, et al.
Publicado: (2021)

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy
por: Koukourakis, Ioannis M., et al.
Publicado: (2022)

Matthäus-Passion, BWV 244 /

HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial
por: Elbers, Joris B. W., et al.
Publicado: (2023)

Review of 244 cases of ovarian cysts
por: Abduljabbar, Hassan S., et al.
Publicado: (2015)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer
por: Yadav, Budhi Singh, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qme1479mat1thc7n6i5at7t8k4